Interviews

Sarah Thomas, Vice President, Public Policy and Communications, NCQA, says that this year the NCQA has a targeted interest in health insurance exchanges and delivery system reforms, such as accountable care organizations and patient-centered medical homes.

Robert Margolis, MD, Managing Partner and CEO, HealthCare Partners, says there needs to be a movement toward managing patients based on population.

Keith Dunleavy, MD, President and CEO, Inovalon, addresses the importance of healthcare data and the digitization of medicine. Dr. Dunleavy states that having quality data allows for more accurate care on an individual level, along with cost savings and a better risk score.

Barry Kinzbrunner, MD, Executive Vice President, Chief Medical Officer, VITAS Corporation, speaks about ways for managed care organizations to reduce hospital readmissions.

Sarah Thomas, Vice President, Public Policy and Communications, NCQA, says there are three options for states looking to initiate health insurance exchanges (HIX): federally facilitated, state sponsored, and partnership models.

Karen Ignagni, President and CEO, America's Health Insurance Plans (AHIP), states that higher costs and reductions in health plan options were consequences of states that did not link Affordable Care Act insurance market reforms and the individual mandate.

In this video, Mary Walsh, Member of the American College of Cardiology Board of Trustees and Chair of the organization's Patient-Centered Care Committee, talks about the efforts being made to truly individualize patient care and move away from a "one-size-fits-all" model in cardiology care.

James C. Capretta, MA, answers what process can be put in place for continual improvement in the productivity and quality of patient care.

Dr. Fenrick discusses the current and forthcoming trends in specialty pharmacy management.

In this video, Steve Marciniak, RPh, speaks of the challenges and value of specialty drugs.

Dr. Lewis addresses reasons why physicians have trouble when getting patients involved in decision making.

Cathleen Biga states that with a good amount of work and significant cost meaningful use can be achieved.

Dr. Nichols thinks a shared savings model without a straight fee cut could be a promising solution to the sustainable growth rate.

In this video, Dr. David Valle, speaks about how genetic variations impact patients' antibodies and immune systems in different ways. "We are beginning to gather the knowledge that is necessary to recognize the key individual differences that determine why patients behave in different ways, even though they have the same diagnostic label," says Valle.

Dr. Singh discusses CVS Caremark's strategies for managing oncology spending.

Michael Einodshofer, RPh, MBA, points out the benefits to members from Site of Care Optimization programs.

Dr. Butler answers why he is not confident that costs will ever be controlled.

Jeff Lemieux discusses health system partnerships that work to control costs in a managed care setting.

Mr. Geraghty points out a variety of ways to engage a health plan's members.

Dr. Dobesh addresses the challenges of achieving efficacy without having the patient bleed when combining anticoagulant and antiplatelet treatments.

Dr. Nichols states that bundling works as an affective payment reform model in cardiology.

Dr. Lewis shares his thoughts on how the patient/provider relationship can be improved.

In this video, Cathleen Biga defines meaningful use and compares the rates of transitions between the hospital setting and smaller practices.

Dr. Casale discuses bundled payments used in cardiology.

In this video, David Nau, PhD, RPh, CPHQ, Senior Director, Quality Strategies Pharmacy Quality Alliance, Inc, discusses a new quality improvement model designed to improve patient medication adherence by utilizing community pharmacists.

In this video, Farzad Mostashari, MD, ScM, National Coordinator for Health Information Technology, US Department of Health and Human Services, addresses ways to reduce regulatory burden in the implementation of meaningful use.

In this video, Dr. Dietrich Stephan, PhD, co-founder of Navigenics, talks about the ways genetic testing and personalized treatments can actually lower costs for payers and patients.

In this video, Felix Frueh, PhD, President, Medco Research, discusses the advancements in personalized medicine over the past decade. Dr. Frueh also speaks about the clinical data that are being generated in order to prove to payers that this area of medicine is not only valuable but also affordable.

Jody L. Miller, CEO Reliance Rx, states that an active pharmacy benefit manager (PBMs) relays good benchmarking data on performance.

Patrick P. Gleason, PharmD, Director of Clinical Outcomes Assessment, Prime Therapeutics, states that the fear of adverse events, cost-sharing and patient education are all factors that keep patients from complying with medication regimens.